Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, replacing the prior Revision: v3.6.5. This reflects a minor update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-29T18:54:06.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small version update to the page.
    Difference
    0.1%
    Check dated 2026-08-08T15:33:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-25T07:46:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3, indicating a minor platform update. No study content or visible details were altered.
    Difference
    0.1%
    Check dated 2026-07-03T23:37:55.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2 instead of v3.6.0. This indicates an updated release of study documents or page content.
    Difference
    0.1%
    Check dated 2026-06-26T23:58:29.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page now indicates that the study is no longer recruiting participants, signaling that enrollment has closed. It also introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Interventions/Treatment header formatting, plus a revision tag update to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-12T16:00:49.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.